500 related articles for article (PubMed ID: 18824350)
61. Design, synthesis and biological evaluation of cycloalkyl arylpyrimidines (CAPYs) as HIV-1 NNRTIs.
Gu SX; Yang SQ; He QQ; Ma XD; Chen FE; Dai HF; Clercq ED; Balzarini J; Pannecouque C
Bioorg Med Chem; 2011 Dec; 19(23):7093-9. PubMed ID: 22037050
[TBL] [Abstract][Full Text] [Related]
62. New pyridinone derivatives as potent HIV-1 nonnucleoside reverse transcriptase inhibitors.
Le Van K; Cauvin C; de Walque S; Georges B; Boland S; Martinelli V; Demonté D; Durant F; Hevesi L; Van Lint C
J Med Chem; 2009 Jun; 52(12):3636-43. PubMed ID: 19469474
[TBL] [Abstract][Full Text] [Related]
63. 5-Alkyl-2-(alkylthio)-6-(2,6-dihalophenylmethyl)-3, 4-dihydropyrimidin-4(3H)-ones: novel potent and selective dihydro-alkoxy-benzyl-oxopyrimidine derivatives.
Mai A; Artico M; Sbardella G; Massa S; Novellino E; Greco G; Loi AG; Tramontano E; Marongiu ME; La Colla P
J Med Chem; 1999 Feb; 42(4):619-27. PubMed ID: 10052969
[TBL] [Abstract][Full Text] [Related]
64. Tetrazole thioacetanilides: potent non-nucleoside inhibitors of WT HIV reverse transcriptase and its K103N mutant.
Muraglia E; Kinzel OD; Laufer R; Miller MD; Moyer G; Munshi V; Orvieto F; Palumbi MC; Pescatore G; Rowley M; Williams PD; Summa V
Bioorg Med Chem Lett; 2006 May; 16(10):2748-52. PubMed ID: 16503141
[TBL] [Abstract][Full Text] [Related]
65. Nonnucleoside HIV-1 reverse transcriptase inhibitors; part 3. Synthesis and antiviral activity of 5-alkyl-2-[(aryl and alkyloxyl-carbonylmethyl)thio]-6-(1-naphthylmethyl) pyrimidin-4(3H)-ones.
He Y; Chen F; Yu X; Wang Y; De Clercq E; Balzarini J; Pannecouque C
Bioorg Chem; 2004 Dec; 32(6):536-48. PubMed ID: 15530994
[TBL] [Abstract][Full Text] [Related]
66. Arylthiopyrrole (AThP) derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors: synthesis, structure-activity relationships, and docking studies (part 1).
Di Santo R; Costi R; Artico M; Miele G; Lavecchia A; Novellino E; Bergamini A; Cancio R; Maga G
ChemMedChem; 2006 Dec; 1(12):1367-78. PubMed ID: 17089433
[TBL] [Abstract][Full Text] [Related]
67. Pyrazole NNRTIs 1: design and initial optimisation of a novel template.
Mowbray CE; Burt C; Corbau R; Perros M; Tran I; Stupple PA; Webster R; Wood A
Bioorg Med Chem Lett; 2009 Oct; 19(19):5599-602. PubMed ID: 19709880
[TBL] [Abstract][Full Text] [Related]
68. Synthesis and anti-HIV activity of new alkenyldiarylmethane (ADAM) non-nucleoside reverse transcriptase inhibitors (NNRTIs) incorporating benzoxazolone and benzisoxazole rings.
Deng BL; Cullen MD; Zhou Z; Hartman TL; Buckheit RW; Pannecouque C; De Clercq E; Fanwick PE; Cushman M
Bioorg Med Chem; 2006 Apr; 14(7):2366-74. PubMed ID: 16321539
[TBL] [Abstract][Full Text] [Related]
69. The design and synthesis of N-1-alkylated-5-aminoarylalkylsubstituted-6-methyluracils as potential non-nucleoside HIV-1 RT inhibitors.
Lu X; Chen Y; Guo Y; Liu Z; Shi Y; Xu Y; Wang X; Zhang Z; Liu J
Bioorg Med Chem; 2007 Dec; 15(23):7399-407. PubMed ID: 17870545
[TBL] [Abstract][Full Text] [Related]
70. Synthesis, anti-HIV-1 activity, and modeling studies of N-3 Boc TSAO compound.
Tomassi C; Nguyen VN; Marco-Contelles J; Balzarini J; Pannecouque C; De Clercq E; Soriano E; Postel D
Bioorg Med Chem Lett; 2008 Apr; 18(7):2277-81. PubMed ID: 18353641
[TBL] [Abstract][Full Text] [Related]
71. Synthesis and biological properties of novel 2-aminopyrimidin-4(3H)-ones highly potent against HIV-1 mutant strains.
Mai A; Artico M; Rotili D; Tarantino D; Clotet-Codina I; Armand-Ugón M; Ragno R; Simeoni S; Sbardella G; Nawrozkij MB; Samuele A; Maga G; Esté JA
J Med Chem; 2007 Nov; 50(22):5412-24. PubMed ID: 17910429
[TBL] [Abstract][Full Text] [Related]
72. Synthesis, structure-activity relationships, and docking studies of N-phenylarylformamide derivatives (PAFAs) as non-nucleoside HIV reverse transcriptase inhibitors.
Ma XD; He QQ; Zhang X; Yang SQ; Yang LM; Gu SX; Zheng YT; Chen FE; Dai HF
Eur J Med Chem; 2012 Dec; 58():504-12. PubMed ID: 23164656
[TBL] [Abstract][Full Text] [Related]
73. Novel 1,1,3-trioxo-2H,4H-thieno[3,4-e][1,2,4]thiadiazine derivatives as non-nucleoside reverse transcriptase inhibitors that inhibit human immunodeficiency virus type 1 replication.
Arranz E; Díaz JA; Ingate ST; Witvrouw M; Pannecouque C; Balzarini J; De Clercq E; Vega S
J Med Chem; 1998 Oct; 41(21):4109-17. PubMed ID: 9767646
[TBL] [Abstract][Full Text] [Related]
74. Synthesis, biological properties and anti-HIV-1 activity of new pyrimidine P1,P2-dinucleotides.
Miazga A; Ziemkowski P; Siwecka MA; Lipniacki A; Piasek A; Kulikowski T
Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):438-44. PubMed ID: 20544533
[TBL] [Abstract][Full Text] [Related]
75. Novel indolyl aryl sulfones active against HIV-1 carrying NNRTI resistance mutations: synthesis and SAR studies.
Silvestri R; De Martino G; La Regina G; Artico M; Massa S; Vargiu L; Mura M; Loi AG; Marceddu T; La Colla P
J Med Chem; 2003 Jun; 46(12):2482-93. PubMed ID: 12773052
[TBL] [Abstract][Full Text] [Related]
76. Design and synthesis of N₁-aryl-benzimidazoles 2-substituted as novel HIV-1 non-nucleoside reverse transcriptase inhibitors.
Monforte AM; Ferro S; De Luca L; Lo Surdo G; Morreale F; Pannecouque C; Balzarini J; Chimirri A
Bioorg Med Chem; 2014 Feb; 22(4):1459-67. PubMed ID: 24457088
[TBL] [Abstract][Full Text] [Related]
77. 5-Alkyl-2-alkylamino-6-(2,6-difluorophenylalkyl)-3,4-dihydropyrimidin-4(3H)-ones, a new series of potent, broad-spectrum non-nucleoside reverse transcriptase inhibitors belonging to the DABO family.
Mai A; Artico M; Ragno R; Sbardella G; Massa S; Musiu C; Mura M; Marturana F; Cadeddu A; Maga G; La Colla P
Bioorg Med Chem; 2005 Mar; 13(6):2065-77. PubMed ID: 15727860
[TBL] [Abstract][Full Text] [Related]
78. Design, synthesis and biological evaluation of 3-benzyloxy-linked pyrimidinylphenylamine derivatives as potent HIV-1 NNRTIs.
Rai D; Chen W; Tian Y; Chen X; Zhan P; De Clercq E; Pannecouque C; Balzarini J; Liu X
Bioorg Med Chem; 2013 Dec; 21(23):7398-405. PubMed ID: 24134904
[TBL] [Abstract][Full Text] [Related]
79. Structure-based bioisosterism design, synthesis and biological evaluation of novel 1,2,4-triazin-6-ylthioacetamides as potent HIV-1 NNRTIs.
Zhan P; Li X; Li Z; Chen X; Tian Y; Chen W; Liu X; Pannecouque C; De Clercq E
Bioorg Med Chem Lett; 2012 Dec; 22(23):7155-62. PubMed ID: 23084898
[TBL] [Abstract][Full Text] [Related]
80. Design, synthesis, biological evaluation, and molecular modeling studies of TIBO-like cyclic sulfones as non-nucleoside HIV-1 reverse transcriptase inhibitors.
Di Santo R; Costi R; Artico M; Ragno R; Lavecchia A; Novellino E; Gavuzzo E; La Torre F; Cirilli R; Cancio R; Maga G
ChemMedChem; 2006 Jan; 1(1):82-95. PubMed ID: 16892340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]